Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Innophos Holdings, Inc. has obtained a Fair Price in its sale to One Rock Capital Partners, LLC
MILWAUKEE, Oct. 21, 2019 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating Innophos (NASDAQ: IPHS) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Innophos to One Rock.
Click here to learn how to join the action: http://ademilaw.com/case/innophos-holdings-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi & O'Reilly, LLP alleges Innophos's financial outlook is improving and yet shareholders will receive only $32.00 per share in cash in a transaction valued at approximately $932 million, including the assumption of debt. One Rock is acquiring Innophos at a substantial discount. The merger agreement unreasonably limits competing bids for Innophos by prohibiting solicitation of further bids, and imposing a termination penalty if Innophos accepts a superior bid. Innophos insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of Innophos' board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Innophos.
If you own common stock in Innophos and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://ademilaw.com/case/innophos-holdings-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi & O'Reilly, LLP
News published on and distributed by:
